
|Articles|August 1, 2000
Postmenopausal HRT and CHD: clinical implications of recent randomized trial res
Results of the HERS, ERA, and WHI trials suggest a conservative approach to use of HRT in women with evidence of CHD. Dose and duration of therapy may be key to the risk-benefit equation.
Advertisement
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
High rates of misdiagnosis reported among perimenopausal women
2
Sleep problems tied to higher hypertension odds in postmenopausal women
3
Deborah Anderson, PhD, calls for expanded contraception access
4
Managing Vasomotor Symptoms with NK3 Receptor Antagonism
5
















